Literature DB >> 9867062

Pathophysiology of diabetic nephropathy.

M E Cooper1, R E Gilbert, M Epstein.   

Abstract

Diabetic nephropathy (DN) is now the commonest cause of end-stage renal failure in the Western world. Recent studies examining the pathogenesis of diabetic complications have focused on the complex interaction between genetic and hemodynamic mechanisms in addition to metabolic factors such as advanced glycation, protein kinase C (PKC) activation, and polyol production. The importance of the various components, particularly with regard to the progression of DN, is currently being explored with the assistance of targeted drug intervention studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867062     DOI: 10.1016/s0026-0495(98)90362-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Nyctanthes arbor-tristis leaf extract ameliorates hyperlipidemia- and hyperglycemia-associated nephrotoxicity by improving anti-oxidant and anti-inflammatory status in high-fat diet-streptozotocin-induced diabetic rats.

Authors:  Sayed Adam Mousum; Sahabuddin Ahmed; Basveshwar Gawali; Mohit Kwatra; Anwaruddin Ahmed; Mangala Lahkar
Journal:  Inflammopharmacology       Date:  2018-06-01       Impact factor: 4.473

2.  Inhibition of Porcine Pancreatic Amylase Activity by Sulfamethoxazole: Structural and Functional Aspect.

Authors:  Sujan Maity; Koel Mukherjee; Amrita Banerjee; Suman Mukherjee; Dipak Dasgupta; Suvroma Gupta
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

3.  Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock.

Authors:  James M Harper; Stephen J Durkee; Michael Smith-Wheelock; Richard A Miller
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

Review 4.  Angiotensin receptor blockers in diabetic nephropathy.

Authors:  D A Price; N K Hollenberg
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

5.  Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

Authors:  Sayeeda Rahman; Aziz Al-Shafi Ismail; Abdul Rashid A Rahman
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07

6.  Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats.

Authors:  Nathani Minaz; Rema Razdan
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

7.  AMPKα, hs-CRP and FcγR in diabetic nephropathy and drug intervention.

Authors:  Ping Sun; Lei Lu; Jun Chen; Xiao Dan Liu; Qing Zhang; Xu Wang
Journal:  Exp Ther Med       Date:  2018-04-04       Impact factor: 2.447

Review 8.  Anti-Diabesity Middle Eastern Medicinal Plants and Their Action Mechanisms.

Authors:  Bashar Saad; Abdalsalam Kmail; Sameena Z H Haq
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-18       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.